Theravance Biopharma Inc $(TBPH)$ is currently at $9.85, up $0.94 or 10.49%
--Would be highest close since Aug. 1, 2024, when it closed at $10.03
--On pace for largest percent increase since Jan. 3, 2022, when it rose 11.13%
--Currently up six of the past seven days
--Up 19.48% month-to-date
--Down 12.41% year-to-date; on pace for worst year since 2021, when it fell 37.82%
--Down 76.87% from its all-time closing high of $42.56 on July 7, 2017
--Down 3.76% from 52 weeks ago (Nov. 15, 2023), when it closed at $10.23
--Down 15.06% from its 52-week closing high of $11.59 on Jan. 3, 2024
--Up 28.52% from its 52-week closing low of $7.66 on Aug. 9, 2024
--Traded as high as $10.26; highest intraday level since July 31, 2024, when it hit $10.35
--Up 15.15% at today's intraday high; largest intraday percent increase since April 12, 2024, when it rose as much as 16.91%
All data as of 11:53:04 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 13, 2024 11:56 ET (16:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。